We identify new CBD susceptibility loci and show that CBD and PSP share a genetic risk factor other than MAPT at 3p22 MOBP (myelin-associated oligodendrocyte basic protein). The gene discussed is MAPT; the disease is supranuclear palsy, progressive, 1.